World Parkinson Congress 2026: Innovations in Care

WPC 2026 — CLOSING DAY DISPATCH

Wednesday, May 27, 2026 | Phoenix Convention Center, Phoenix, Arizona

WORLD PARKINSON CONGRESS REACHES FINAL DAY IN PHOENIX

The 7th World Parkinson Congress wraps up today after four days at the Phoenix Convention Center, drawing more than 4,000 neurologists, scientists, nurses, rehabilitation experts, people with Parkinson’s, and care partners from around the world. It marks the first time in 10 years the WPC has been held in North America.

TODAY’S HOT TOPICS — THE FINAL FOUR

The WPC’s Hot Topics format features four presentations per day just before the opening plenary, drawn from more than 900 submitted abstracts reviewed by over 50 experts. The final day’s presentations close out a 12-presentation series spanning the full congress. Among the research highlighted across the week:

Skin biomarker for pre-Parkinson’s: Christopher Gibbons (USA) presented findings from the Syn-Sleep Study on the detection of cutaneous phosphorylated alpha-synuclein in REM sleep behavior disorder — a potentially significant early marker for synucleinopathy.

Air pollution and Parkinson’s neurotoxicity: Emeline Barbier (France) presented research on the impact of ultrafine particles from air pollution on Parkinson’s disease, tracing their path from brain biodistribution to neurotoxicity.

Predicting Parkinson’s before symptoms: Ashvin Kuri (UK) examined prodromal disease algorithms in the PREDICT-PD study, exploring how early warning signs can be systematically identified.

Genetics and neuroinflammation: Research on how Parkinson’s disease genetic risk modulates microglia transcriptional states in alpha-synucleinopathies was also featured.

Freezing of gait imaging: Nicolaas Bohnen (USA) presented whole-brain dopamine transporter PET imaging data in Parkinson’s patients with freezing of gait or a history of falls.

OVERARCHING THEME: BEYOND THE BRAIN

The congress theme — “Parkinson’s Beyond the Brain: A (More) Holistic Approach to PD” — shaped four days of pre-congress courses, plenary sessions, hot topic presentations, poster tours, parallel talks, and small roundtable sessions. For the first time in WPC history, the program introduced controversy sessions, allowing for open debates on key topics in Parkinson’s research and care.

SCIENCE MEETS COMMUNITY

The congress featured 760 scientific and living-with-Parkinson’s posters, a Clinical Research Village connecting researchers with potential trial participants, a Creativity Program, and wellness spaces including a Renewal Room, Massage & Wellness room, and a Care Partner Classroom & Lounge.

LOOKING AHEAD

WPC Executive Director Elizabeth Pollard noted that the research showcased — spanning genetics, diagnostics, and day-to-day disease management — reflects how the global Parkinson’s community is working toward improving disease management while pursuing a cure. The next World Parkinson Congress is expected in 2029.

Note: Live session-by-session reporting from today’s closing ceremonies was not yet indexed at time of publication. Check wpc2026.org and @WorldPDCongress for real-time updates.

Check out the conference on their Facebook page!

WORLD PARKINSON CONGRESS 2026 — DAY THREE DISPATCH
Phoenix Convention Center, Phoenix, Arizona | Tuesday, May 26, 2026

PHOENIX, AZ — The third day of the 7th World Parkinson Congress has drawn scientists, clinicians, care partners, and people living with Parkinson’s disease from across the globe to the Phoenix Convention Center, where a packed programme of sessions is exploring the frontiers of Parkinson’s research and care.

The congress, hosted by the World Parkinson Coalition and running May 24–27, marks the event’s return to North America for the first time in a decade — a milestone underscored by a full schedule of plenary sessions, poster tours, roundtables, and the deeply personal “Living Positively with Parkinson’s” panel discussion taking place today.

Today’s most anticipated session sees Cure Parkinson’s Director of Research, Dr. Simon Stott, deliver a presentation on the disease-modifying therapy pipeline — an update eagerly awaited by the global Parkinson’s community. The session runs from 9 to 11am and is followed by a poster session showcasing ongoing research across topics ranging from gut health and inflammation to exercise and emerging therapies.

The “Living Positively with Parkinson’s” panel, also held today, reflects the congress’s uniquely inclusive ethos — one of the few international Parkinson’s meetings to bring people living with PD, care partners, and leading researchers into the same room.

12 Hot Topics Selected from Over 900 Submissions

Leading into the congress, the World Parkinson Coalition announced its 12 Hot Topics presentations — a prestigious selection drawn from more than 900 submissions and reviewed by a panel of over 50 international experts. Four are delivered each morning just before the opening plenary, spanning basic science, clinical science, therapeutics, and care. Selected topics include predicting Parkinson’s using prodromal disease algorithms, the role of cutaneous alpha-synuclein detection in REM sleep behaviour disorder, the impact of air pollution on Parkinson’s risk, and dopamine transporter PET imaging in patients experiencing freezing of gait.

Genetics and Precision Medicine

The Parkinson’s Foundation is presenting findings from its PD GENEration study at WPC, highlighting the role of genetics in precision medicine and addressing barriers to participation in genetic-focused clinical trials. The international study has so far empowered more than 20,000 people with Parkinson’s with information on genetic risk factors that can influence the course of their disease.

The congress concludes tomorrow, Wednesday, May 27. For those unable to attend in person, several organisations including Cure Parkinson’s have pledged to publish post-congress highlights on their websites. Live updates can be followed at #WPC2026 and at wpc2026.org.

4/25 Update

Update #2

New Scientific Themes and Major Announcements Emerge at World Parkinson Congress 2026

Nearly 4000 attendees from 62 different countries have come to phoenix to attend this year’s world, Parkinson’s Congress. New announcements and scientific developments continue to emerge from the 7th World Parkinson Congress (WPC 2026), as thousands of researchers, neurologists, advocates, caregivers, and people living with Parkinson’s disease gather in Phoenix for one of the largest international Parkinson’s meetings in the world.

One of the biggest announcements made during the congress was the confirmation that the next World Parkinson Congress will take place in Québec City, Canada in 2029. Organizers revealed the news during opening events in Phoenix, marking Canada’s return as host of the global Parkinson’s gathering for the first time since Montréal hosted in 2013.

Scientific discussions at WPC 2026 are increasingly centering around biomarkers, genetics, artificial intelligence, inflammation, and personalized medicine approaches aimed at identifying Parkinson’s disease earlier and more precisely. Sessions throughout the congress are exploring how blood biomarkers, alpha-synuclein testing, wearable monitoring systems, imaging technologies, and genetic screening may help researchers better classify Parkinson’s disease into biologically distinct subtypes rather than viewing it as one uniform condition.

The Parkinson’s Foundation is also expanding its PD GENEration initiative during the congress by offering on-site genetic testing and counseling opportunities for attendees living with Parkinson’s disease. Organizers say more than 20,000 participants have already contributed to the ongoing genetics-focused program, which is designed to better understand how genes such as LRRK2, GBA, and SNCA may influence disease progression and treatment responses.

Additional research-related announcements tied to WPC 2026 include new biomarker-focused therapeutic data from Vanqua Bio, which announced positive interim findings from an ongoing Phase 1b Parkinson’s study being presented during meetings taking place alongside the congress in Phoenix.

Human-interest and advocacy stories are also drawing attention during the event. Australian neurologist and Parkinson’s patient David Blacker is presenting both his personal Parkinson’s journey and scientific observations at the congress, reflecting WPC’s continued emphasis on directly involving people living with Parkinson’s within scientific discussions and research conversations.

Another widely discussed event surrounding the congress is the completion of the “Pedal to Phoenix” cycling campaign, which arrived in Phoenix this week to raise awareness for Parkinson’s disease ahead of WPC opening ceremonies.

Researchers and organizations attending WPC 2026 continue to emphasize that the field is rapidly moving toward prevention-focused trials, AI-assisted disease tracking, digital health monitoring, and more individualized treatment strategies. Many experts now believe Parkinson’s disease may involve overlapping biological systems tied to inflammation, immune dysfunction, mitochondrial damage, alpha-synuclein accumulation, and additional co-pathologies beyond dopamine loss alone.

New announcements emerging from the World Parkinson Congress 2026 suggest the international meeting is placing major emphasis on biomarkers, genetics, prevention science, artificial intelligence, and personalized medicine approaches as thousands of researchers, clinicians, advocates, caregivers, and people living with Parkinson’s gather in Arizona this week.

One of the biggest developments announced ahead of the congress is the unveiling of the event’s 12 “Hot Topics” presentations, which organizers say were selected to showcase some of the most rapidly developing areas in Parkinson’s research and disease management. The sessions are expected to focus on emerging findings in basic science, clinical care, therapeutics, rehabilitation, and complementary approaches to treatment.

The scientific program also signals a noticeable shift toward earlier disease detection and prevention-focused research. Several WPC-associated sessions are centered on identifying Parkinson’s disease before major motor symptoms appear through the use of alpha-synuclein biomarkers, genetic screening, REM sleep behavior disorder assessments, and advanced imaging tools. Researchers are increasingly discussing how future prevention trials could target individuals considered biologically “at risk” for Parkinson’s disease years before traditional diagnosis.

Genetics is expected to play a central role throughout the congress. Expanded PD GENEration initiatives tied to the meeting will offer genetic testing and counseling while highlighting research involving genes such as LRRK2, GBA, and SNCA. Scientists now increasingly believe Parkinson’s disease may represent multiple biologically distinct subtypes rather than a single uniform disorder.

Artificial intelligence and digital health technologies are also gaining attention at WPC 2026. Sessions are expected to explore how wearable devices, smartwatches, speech analysis systems, gait monitoring tools, and AI-assisted analytics may help researchers better track disease progression and personalize treatment strategies outside traditional clinic settings.

Another growing theme involves the broader biological complexity of Parkinson’s disease itself. Researchers are increasingly examining how inflammation, immune dysfunction, mitochondrial damage, alpha-synuclein accumulation, tau pathology, and possible TDP-43 involvement may interact together across multiple body systems instead of viewing Parkinson’s strictly as dopamine neuron loss alone.

Additional announcements tied to the congress include the launch of the Parkinson Ready™ Phoenix accessibility initiative, advocacy cycling campaigns arriving in Phoenix, and expanded support programs aimed at helping younger Parkinson’s researchers navigate growing funding pressures within the scientific community.

4/24 Update!

New updates continue to emerge from the World Parkinson Congress 2026 as the congress officially opens in Phoenix. One of the biggest recent announcements is the release of the 12 “Hot Topics” presentations, highlighting emerging research areas in Parkinson’s disease management and science. Organizers have also finalized the scientific program, which includes sessions on genetics, gut-brain research, inflammation, rehabilitation, caregiving, AI-assisted diagnostics, and emerging therapeutics.

The Parkinson’s Foundation announced expanded participation at the event, including on-site PD GENEration genetic testing and counseling for attendees living with Parkinson’s. Additional attention is being placed on accessibility through the “Parkinson Ready™ Phoenix” initiative, which trains hospitality and transportation workers to better assist visitors living with Parkinson’s during the congress. Community engagement projects tied to the event continue to gain visibility as well, including nationwide cycling awareness rides converging in Phoenix and the ongoing Parkinson’s Red Thread Project art campaign.

4/23 Update!

The World Parkinson Congress 2026 is set to begin May 24 in Phoenix, marking the first time in a decade the international Parkinson’s gathering has returned to North America. Organizers expect more than 4,000 researchers, neurologists, clinicians, advocates, caregivers, and people living with Parkinson’s to attend. Recent announcements highlight a major focus on genetics, personalized medicine, biomarkers, AI-assisted diagnostics, rehabilitation, caregiving, and emerging therapies, with more than 800 scientific abstracts expected to be presented. The Parkinson’s Foundation will also offer on-site PD GENEration genetic testing and counseling through a dedicated pavilion. Organizers continue promoting the “Parkinson Ready™ Phoenix” initiative, designed to help hospitality and public service workers better support visitors living with Parkinson’s during the congress. Additional community-driven events, including the “Pedal to Phoenix” cycling initiative and the Parkinson’s Red Thread Project art campaign, are also drawing attention ahead of the event.